↓ Skip to main content

Baricitinib decreases anti-dsDNA in patients with systemic lupus erythematosus: results from a phase II double-blind, randomized, placebo-controlled trial

Overview of attention for article published in Arthritis Research & Therapy, May 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter
4 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
29 Mendeley